Arlen PM - Search Results

1

Potentiation of natural killer cells to overcome cancer resistance to NK cell-based therapy and to enhance antibody-based immunotherapy.

Fantini M, Arlen PM, Tsang KY. Fantini M, et al. Among authors: arlen pm. Front Immunol. 2023 Nov 24;14:1275904. doi: 10.3389/fimmu.2023.1275904. eCollection 2023. Front Immunol. 2023. PMID: 38077389 Free PMC article. Review.

2

Preclinical Characterization of a Novel Monoclonal Antibody NEO-201 for the Treatment of Human Carcinomas.

Fantini M, David JM, Saric O, Dubeykovskiy A, Cui Y, Mavroukakis SA, Bristol A, Annunziata CM, Tsang KY, Arlen PM. Fantini M, et al. Among authors: arlen pm. Front Immunol. 2018 Jan 4;8:1899. doi: 10.3389/fimmu.2017.01899. eCollection 2017. Front Immunol. 2018. PMID: 29354121 Free PMC article.

3

Evaluation of the Anti-Tumor Activity of the Humanized Monoclonal Antibody NEO-201 in Preclinical Models of Ovarian Cancer.

Zeligs KP, Morelli MP, David JM, Neuman M, Hernandez L, Hewitt S, Ozaki M, Osei-Tutu A, Anderson D, Andresson T, Das S, Lack J, Abdelmaksoud A, Fantini M, Arlen PM, Tsang KY, Annunziata CM. Zeligs KP, et al. Among authors: arlen pm. Front Oncol. 2020 Jun 19;10:805. doi: 10.3389/fonc.2020.00805. eCollection 2020. Front Oncol. 2020. PMID: 32637350 Free PMC article.

4

New gene expressed in prostate: a potential target for T cell-mediated prostate cancer immunotherapy.

Cereda V, Poole DJ, Palena C, Das S, Bera TK, Remondo C, Gulley JL, Arlen PM, Yokokawa J, Pastan I, Schlom J, Tsang KY. Cereda V, et al. Among authors: arlen pm. Cancer Immunol Immunother. 2010 Jan;59(1):63-71. doi: 10.1007/s00262-009-0723-6. Epub 2009 Jun 4. Cancer Immunol Immunother. 2010. PMID: 19495750 Free PMC article.

5

Analysis of circulating regulatory T cells in patients with metastatic prostate cancer pre- versus post-vaccination.

Vergati M, Cereda V, Madan RA, Gulley JL, Huen NY, Rogers CJ, Hance KW, Arlen PM, Schlom J, Tsang KY. Vergati M, et al. Among authors: arlen pm. Cancer Immunol Immunother. 2011 Feb;60(2):197-206. doi: 10.1007/s00262-010-0927-9. Epub 2010 Oct 26. Cancer Immunol Immunother. 2011. PMID: 20976449 Free PMC article. Clinical Trial.

6

An IL-15 Superagonist, ALT-803, Enhances Antibody-Dependent Cell-Mediated Cytotoxicity Elicited by the Monoclonal Antibody NEO-201 Against Human Carcinoma Cells.

Fantini M, David JM, Wong HC, Annunziata CM, Arlen PM, Tsang KY. Fantini M, et al. Among authors: arlen pm. Cancer Biother Radiopharm. 2019 Apr;34(3):147-159. doi: 10.1089/cbr.2018.2628. Epub 2019 Jan 2. Cancer Biother Radiopharm. 2019. PMID: 30601063 Free PMC article.

7

Phase II Study of Ensituximab, a Novel Chimeric Monoclonal Antibody, in Adults with Unresectable, Metastatic Colorectal Cancer.

Kim RD, Azad NS, Morse MA, Poplin E, Mahipal A, Tan B Jr, Mavroukakis SA, Fantini M, Tsang KY, Zaki A, Torrealba J, Arlen PM, Beg MS. Kim RD, et al. Among authors: arlen pm. Clin Cancer Res. 2020 Jul 15;26(14):3557-3564. doi: 10.1158/1078-0432.CCR-20-0426. Epub 2020 Apr 17. Clin Cancer Res. 2020. PMID: 32303539 Clinical Trial.

8

Development and Characterization of an Anti-Cancer Monoclonal Antibody for Treatment of Human Carcinomas.

Tsang KY, Fantini M, Mavroukakis SA, Zaki A, Annunziata CM, Arlen PM. Tsang KY, et al. Among authors: arlen pm. Cancers (Basel). 2022 Jun 21;14(13):3037. doi: 10.3390/cancers14133037. Cancers (Basel). 2022. PMID: 35804808 Free PMC article. Review.

9

Identification of the O-Glycan Epitope Targeted by the Anti-Human Carcinoma Monoclonal Antibody (mAb) NEO-201.

Tsang KY, Fantini M, Zaki A, Mavroukakis SA, Morelli MP, Annunziata CM, Arlen PM. Tsang KY, et al. Among authors: arlen pm. Cancers (Basel). 2022 Oct 12;14(20):4999. doi: 10.3390/cancers14204999. Cancers (Basel). 2022. PMID: 36291783 Free PMC article.

10

First-in-human phase 1 clinical trial of anti-core 1 O-glycans targeting monoclonal antibody NEO-201 in treatment-refractory solid tumors.

Cole CB, Morelli MP, Fantini M, Miettinen M, Fetsch P, Peer C, Figg WD, Yin T, Houston N, McCoy A, Lipkowitz S, Zimmer A, Lee JM, Pavelova M, Villanueva EN, Trewhitt K, Solarz BB, Fergusson M, Mavroukakis SA, Zaki A, Tsang KY, Arlen PM, Annunziata CM. Cole CB, et al. Among authors: arlen pm. J Exp Clin Cancer Res. 2023 Mar 29;42(1):76. doi: 10.1186/s13046-023-02649-6. J Exp Clin Cancer Res. 2023. PMID: 36991390 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

111 results

Search Page